LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
94,100
-1,900 (-1.98%)
Mar 28, 2025, 3:30 PM KST
23.82%
Market Cap 3.41T
Revenue (ttm) 125.90B
Net Income (ttm) 7.80B
Shares Out 36.28M
EPS (ttm) 224.00
PE Ratio 437.70
Forward PE 28.00
Dividend n/a
Ex-Dividend Date n/a
Volume 247,477
Average Volume 358,894
Open 96,600
Previous Close 96,000
Day's Range 93,700 - 97,500
52-Week Range 58,800 - 143,600
Beta 1.04
RSI 31.65
Earnings Date Mar 21, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 163
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.